Corvus Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 May 24 | BuyUS$34,624 | William Jones | Individual | 20,000 | US$1.73 | |
06 May 24 | BuyUS$1,000,000 | Richard Miller | Individual | 577,634 | US$1.73 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,211,954 | 3.54% |
Institutions | 9,789,279 | 15.7% |
Hedge Funds | 10,103,088 | 16.2% |
VC/PE Firms | 10,219,270 | 16.3% |
General Public | 30,227,690 | 48.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,943,654 | US$63.8m | 0% | 0.85% | |||
5,572,755 | US$51.2m | -6.95% | 0.12% | |||
4,530,333 | US$41.7m | -26% | 0.63% | |||
3,275,616 | US$30.1m | 0% | 27.21% | |||
2,420,619 | US$22.3m | 46.7% | no data | |||
1,765,737 | US$16.2m | 0% | no data | |||
1,497,268 | US$13.8m | 0% | 1.12% | |||
603,877 | US$5.6m | 7.45% | no data | |||
563,009 | US$5.2m | 22.4% | no data | |||
500,000 | US$4.6m | 0% | 1.67% | |||
393,262 | US$3.6m | 5.89% | no data | |||
386,588 | US$3.6m | -31.5% | no data | |||
376,121 | US$3.5m | 0% | no data | |||
331,360 | US$3.0m | 0% | 0.02% | |||
323,211 | US$3.0m | 334% | no data | |||
311,288 | US$2.9m | 52.2% | no data | |||
282,444 | US$2.6m | 0% | no data | |||
218,962 | US$2.0m | 754% | no data | |||
178,246 | US$1.6m | 48.2% | no data | |||
153,773 | US$1.4m | 0% | no data | |||
137,031 | US$1.3m | 64.7% | 0.01% | |||
127,332 | US$1.2m | 0% | no data | |||
127,300 | US$1.2m | 0% | 0.02% | |||
122,858 | US$1.1m | 0% | no data | |||
117,500 | US$1.1m | -70.6% | 0.71% |